|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBOOKCENTRAL_on1045639697 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
180719s2018 mdua ob 001 0 eng |
010 |
|
|
|a 2018034700
|
040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d N$T
|d YDX
|d EBLCP
|d OCLCF
|d YDX
|d I3U
|d N$T
|d OTZ
|d TKN
|d OCLCQ
|d SFB
|d UKAHL
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1262324669
|
020 |
|
|
|a 9781498574174
|q (electronic bk.)
|
020 |
|
|
|a 1498574173
|q (electronic bk.)
|
020 |
|
|
|z 9781498574167
|q (hardcover
|q alkaline paper)
|
029 |
1 |
|
|a AU@
|b 000071300849
|
035 |
|
|
|a (OCoLC)1045639697
|z (OCoLC)1262324669
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
050 |
1 |
4 |
|a HF6161.D7
|b D42 2018
|
072 |
|
7 |
|a BUS
|x 002000
|2 bisacsh
|
082 |
0 |
0 |
|a 659.19/615108900973
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a De Scisciolo, Stephany,
|d 1958-
|e author.
|
245 |
1 |
0 |
|a Reducing race differences in direct-to-consumer pharmaceutical advertising :
|b the case for regulation /
|c Stephany De Scisciolo and Teresa L. Scheid.
|
264 |
|
1 |
|a Lanham, Maryland :
|b Lexington Books, an imprint of The Rowman & Littlefield Publishing Group, Inc.,
|c [2018]
|
300 |
|
|
|a 1 online resource (xix, 119 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Introduction: health disparities and pharmaceutical advertising -- The pharmaceutical industry, direct to consumer advertising, and racial differences -- Direct to consumer advertising: patient empowerment or manipulation? -- Comparative analysis of the frequency and type of DTCA -- Differences in the appearance and content of DTCA -- Examination of the visual content of DTCA -- Conclusion: a missed opportunity: policy implications.
|
520 |
|
|
|a This book examines whether direct-to-consumer pharmaceutical advertising changed in response to recommendations made by the FDA in 2009 to enhance the informational and motivational value of advertising to be more accessible to minority populations and consequently work to reduce health disparities.
|
588 |
0 |
|
|a Online resource; title from digital title page (viewed on September 24, 2018).
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Advertising
|x Drugs
|z United States.
|
650 |
|
0 |
|a Direct-to-consumer prescription drug advertising
|z United States.
|
650 |
|
0 |
|a Discrimination in the advertising industry
|z United States.
|
650 |
|
0 |
|a Discrimination in medical care
|z United States.
|
650 |
|
6 |
|a Médicaments
|x Publicité
|z États-Unis.
|
650 |
|
6 |
|a Publicité directe des médicaments d'ordonnance
|z États-Unis.
|
650 |
|
6 |
|a Discrimination dans les soins médicaux
|z États-Unis.
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Advertising & Promotion.
|2 bisacsh
|
650 |
|
7 |
|a Advertising
|x Drugs
|2 fast
|
650 |
|
7 |
|a Direct-to-consumer prescription drug advertising
|2 fast
|
650 |
|
7 |
|a Discrimination in medical care
|2 fast
|
650 |
|
7 |
|a Discrimination in the advertising industry
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|
700 |
1 |
|
|a Scheid, Teresa L.,
|e author.
|
776 |
0 |
8 |
|i Print version:
|a De Scisciolo, Stephany, 1958-
|t Reducing race differences in direct to consumer pharmaceutical advertising.
|d Lanham : Lexington Books, [2018]
|z 9781498574167
|w (DLC) 2018032142
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5492310
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5492310
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1857399
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15616335
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH34621613
|
994 |
|
|
|a 92
|b IZTAP
|